These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 7826702)

  • 1. Antiviral treatment of feline immunodeficiency virus-infected cats with (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine.
    Taffin E; Paepe D; Goris N; Auwerx J; Debille M; Neyts J; Van de Maele I; Daminet S
    J Feline Med Surg; 2015 Feb; 17(2):79-86. PubMed ID: 24782459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine (PMPDAP) in the treatment of feline immunodeficiency virus-infected cats.
    Hartmann AD; Wilhelm N; Balzarini J; Hartmann K
    J Feline Med Surg; 2012 Feb; 14(2):107-12. PubMed ID: 22314085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages.
    Aquaro S; Borrajo A; Pellegrino M; Svicher V
    Virulence; 2020 Dec; 11(1):400-413. PubMed ID: 32375558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocytes as Carriers: From Drug Delivery to Biosensors.
    Koleva L; Bovt E; Ataullakhanov F; Sinauridze E
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32197542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.
    Nelson AG; Zhang X; Ganapathi U; Szekely Z; Flexner CW; Owen A; Sinko PJ
    J Control Release; 2015 Dec; 219():669-680. PubMed ID: 26315816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal structural design of mannosylated nanocarriers for macrophage targeting.
    Chen P; Zhang X; Jia L; Prud'homme RK; Szekely Z; Sinko PJ
    J Control Release; 2014 Nov; 194():341-9. PubMed ID: 25220160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of feline immunodeficiency virus (FIV).
    Mohammadi H; Bienzle D
    Viruses; 2012 May; 4(5):708-24. PubMed ID: 22754645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inside out of lentiviral vectors.
    Durand S; Cimarelli A
    Viruses; 2011 Feb; 3(2):132-159. PubMed ID: 22049307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier.
    Saiyed ZM; Gandhi NH; Nair MP
    Int J Nanomedicine; 2010 Apr; 5():157-66. PubMed ID: 20463931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.
    Gunaseelan S; Gunaseelan K; Deshmukh M; Zhang X; Sinko PJ
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):518-31. PubMed ID: 19941919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AZT 5'-triphosphate nanoformulation suppresses human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells.
    Saiyed ZM; Gandhi NH; Nair MP
    J Neurovirol; 2009 Jul; 15(4):343-7. PubMed ID: 19575326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linked polymeric nanogel formulations of 5'-triphosphates of nucleoside analogues: role of the cellular membrane in drug release.
    Vinogradov SV; Kohli E; Zeman AD
    Mol Pharm; 2005; 2(6):449-61. PubMed ID: 16323952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related dynamics of constitutive cytokine transcription levels of feline monocytes.
    Kipar A; Baptiste K; Meli ML; Barth A; Knietsch M; Reinacher M; Lutz H
    Exp Gerontol; 2005 Mar; 40(3):243-8. PubMed ID: 15763402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline immunodeficiency virus infection: an overview.
    Hartmann K
    Vet J; 1998 Mar; 155(2):123-37. PubMed ID: 9564266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
    Magnani M; Casabianca A; Fraternale A; Brandi G; Gessani S; Williams R; Giovine M; Damonte G; De Flora A; Benatti U
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4403-8. PubMed ID: 8633079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.
    Bendinelli M; Pistello M; Lombardi S; Poli A; Garzelli C; Matteucci D; Ceccherini-Nelli L; Malvaldi G; Tozzini F
    Clin Microbiol Rev; 1995 Jan; 8(1):87-112. PubMed ID: 7704896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline immunodeficiency virus infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate-loaded erythrocytes.
    Magnani M; Rossi L; Fraternale A; Silvotti L; Quintavalla F; Piedimonte G; Matteucci D; Baldinotti F; Bendinelli M
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1179-86. PubMed ID: 7826702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5'-triphosphate.
    Magnani M; Rossi L; Fraternale A; Silvotti L; Quintavalla F; Piedimonte G; Matteucci D; Baldinotti F; Bendinelli M
    Vet Immunol Immunopathol; 1995 May; 46(1-2):151-8. PubMed ID: 7618255
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.